Alyeska Investment Group, L.P.

Q4 2020 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Brent Cunningham - Chief Compliance Officer
Location
Chicago, IL
Holdings as of
December 31, 2020
Value $
$175M
Num holdings
5
Date filed
8/24/2021, 03:35 PM
Description
Request for Confidential Treatment (2/16/2021): Confidential Treatment Expired on 8/16/2021. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q3 2020 - Nov 16, 2020
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 02-16-2021 pursuant to a request for confidential treatment and for which confidential treatment expired on 08-16-2021.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Brent Cunningham Chief Compliance Officer Chicago, Illinois 8/24/2021

Other Included Managers (2):

Num Name Location File Number
1 Alyeska Master Fund, L.P. Chicago, IL 028-13417
2 Alyeska Master Fund 3, L.P. 028-19522